Psilocybin and the Aging Brain: What the Research Shows So Far
Research into psilocybin aging effects is accelerating, with preclinical studies pointing to neuroplasticity promotion, reduced neuroinflammation, and improvements in longevity biomarkers. The findings are genuinely interesting,...
How to Talk to Your Doctor About Psychedelic Therapy
Talking to your doctor about psychedelic therapy is one of the most common points where people get stuck. This guide walks you through how to frame...
5-MeO-DMT Therapy: What the Research Shows and Why Risks Are Real
5-MeO-DMT therapy is attracting serious interest from researchers, executives, and people seeking relief from depression, anxiety, and trauma. The compound is potent, fast-acting, and increasingly the...
Psychedelic Therapy in Portugal: What American Seekers Should Know
Last Updated: May 2026 Portugal has become one of the most visited destinations for psychedelic therapy in Europe, largely because of its 2001 policy of decriminalizing...
How Much Does Psychedelic Therapy Cost and Why Cheap Is Risky
How much does psychedelic therapy cost? Depending on the modality, setting, and level of support, a full course of professionally supported treatment in the United States...
Psilocybin OCD Treatment: What the Early Research Shows
Psilocybin OCD treatment is a small but growing area of clinical research, with early data suggesting meaningful symptom reductions for people who have not responded to...
Psychedelic Therapy in Georgia, Tennessee & the Carolinas: Access Now
Last Updated: May 2026 Psychedelic therapy Georgia seekers can access today is primarily ketamine-based, with FDA-cleared options available in Atlanta, Nashville, and Asheville. Psilocybin remains a...
Psychedelic Therapy in Pennsylvania: Philadelphia, Pittsburgh & Legal Access
Psychedelic therapy in Pennsylvania is at an early but real stage of development. Ketamine is the only legally available psychedelic-assisted treatment within the state right now,...
Psilocybin for End-of-Life Anxiety: What the Research Shows
Research into psilocybin for end-of-life anxiety has produced some of the most compelling clinical data in psychedelic science. Landmark trials at Johns Hopkins and NYU found...
Psychedelic Therapy Contraindications: Who Should Pause First
Psychedelic therapy contraindications include a personal history of psychosis or mania, current lithium use, certain cardiac conditions, and active suicidal ideation with intent. Some of these...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.